Finance Home
-
My Yahoo
-
Yahoo!
-
Help
Sunday, December 6, 2009, 3:12PM ET - U.S. Markets Closed.
Dow
0.22%
Nasdaq
0.98%
Home
Investing
Market Overview
Market Stats
Stocks
Mutual Funds
ETFs
Bonds
Options
Industries
Currencies
New!
Education
News & Opinion
Markets
Investing Ideas
Expert Advice
Special Editions
Company Finances
Providers
Personal Finance
Banking & Budgeting
Career & Work
College & Education
Family & Home
Insurance
Loans
Real Estate
Retirement
Taxes
How-to Guides
My Portfolios
Sign In to Create/Edit My Portfolios
Free trial of Real-Time Quotes
Tech Ticker
Get Quotes
Finance Search
DUSA Pharmaceuticals Inc. (DUSA)
On
Dec 4
:
1.35
0.02
(1.46%)
MORE ON DUSA
Quotes
Summary
Real-Time
Options
Historical Prices
Charts
Interactive
Basic Chart
Basic Tech. Analysis
News & Info
Headlines
Financial Blogs
Company Events
Message Board
Company
Profile
Key Statistics
SEC Filings
Competitors
Industry
Components
Analyst Coverage
Analyst Opinion
Analyst Estimates
Research Reports
Star Analysts
Ownership
Major Holders
Insider Transactions
Insider Roster
Financials
Income Statement
Balance Sheet
Cash Flow
Industry: Drug Manufacturers - Other
Get
Industry
for:
DUSA SECTOR / INDUSTRY MEMBERSHIP
Sector:
Healthcare
Industry:
Drug Manufacturers - Other
INTRADAY PERFORMANCE SUMMARY
Name
Ticker
Change
DUSA Pharmaceuticals Inc.
DUSA
1.46%
Drug Manufacturers - Other
^YHOh784
0.01%
View Drug Manufacturers - Other Industry Center
DRUG MANUFACTURERS - OTHER INDUSTRY NEWS
Researchers Report Clinical Association Between Type II PNH Cells and Thrombocytopenia
Sun 10:00 AM - Business Wire
SolirisĀ® Reduced Hemolysis, Decreased Transfusion Requirements and Improved Fatigue in Patients with PNH and Bone Marrow Insufficiency Disorders
Sun 10:00 AM - Business Wire
Playing Dr. Reddy's Meteoric Rise
Sun 5:42 AM - at Seeking Alpha
Long-Term SolirisĀ® Treatment Resulted in Sustained Reduction in Hemolysis and Improved Kidney Function in Japanese Patients with PNH
Sat 10:00 AM - Business Wire
Allos Therapeutics Reports New Analyses of Data from Pivotal PROPEL Trial of FOLOTYN at 51st ASH Annual Meeting
Sat 10:00 AM - Business Wire
Santarus Receives FDA Approval for Immediate-Release Omeprazole Tablet with Dual Buffers
Fri 7:08 PM - Business Wire
More Industry News...
TOP DRUG MANUFACTURERS - OTHER COMPANIES BY MARKET CAP
Company
Symbol
Price
Change
Market Cap
P/E
Teva Pharmaceutical Industries Limited
TEVA
54.01
0.82%
47.58B
49.41
Novo Nordisk A/S
NVO
67.11
0.81%
40.02B
18.75
Allergan Inc.
AGN
59.16
0.70%
17.98B
32.12
Forest Laboratories Inc.
FRX
31.20
0.10%
9.42B
12.92
Vertex Pharmaceuticals Incorporated
VRTX
39.63
1.47%
7.18B
N/A
DUSA Pharmaceuticals Inc.
DUSA
1.35
1.46%
32.55M
N/A
Showing 1 - 5 of 74 -
View All
More Top Companies:
by Performance
,
by Valuation
,
by Growth
,
more...
DUSA VS. INDUSTRY LEADERS
Statistic
Industry Leader
DUSA
DUSA Rank
Market Capitalization
TEVA
47.58B
32.55M
65 / 74
P/E Ratio (ttm)
CPIX
59.91
N/A
N/A
PEG Ratio (ttm, 5 yr expected)
SCR
2.46
N/A
N/A
Revenue Growth (Qtrly YoY)
ACCP.OB
206.40%
21.00%
24 / 74
EPS Growth (Qtrly YoY)
WCRX
955.10%
N/A
N/A
Long-Term Growth Rate (5 yr)
PTIE
83.8%
N/A
N/A
Return on Equity (ttm)
CBST
65.94%
-28.37%
30 / 74
Long-Term Debt/Equity (mrq)
N/A
Dividend Yield (annual)
TPI
2.30%
N/A
N/A
View Leaders & Laggards
MORE ON DRUG MANUFACTURERS - OTHER
Industry Summary
News
Leaders & Laggards
Company List
Industry Calendar
RELATED INDUSTRIES
Biotechnology
Diagnostic Substances
Drug Delivery
Drug Manufacturers - Major
Drug Related Products
Drugs - Generic
Top Performing Industries
|
Complete Industry List
Add to Portfolio
Set Alert
Email to a Friend
Get
Industry
for Another Symbol:
Symbol Lookup
Research Reports Screener
Industry Center